» Articles » PMID: 660282

Clinical Comparison of Cardiac Blood Pool Visualization with Technetium-99m Red Blood Cells Labeled in Vivo and with Technetium-99m Human Serum Albumin

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 1978 Jul 1
PMID 660282
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Technetium-99m red blood cells (Tc-RBC) labeled by an in vivo technique were compared with two preparations of Tc-99m human serum albumin (HSA) for cardiac blood-pool imaging. Relative distribution of the tracers was analyzed on end-diastolic frames of gated blood-pool studies and on whole-body (head to mid-thigh) anterior pinhole images. The Tc-RBC demonstrated greater relative percentage localization in the cardiac blood pool, higher target-to-background ratios in the left ventricle, and less liver concentration. For cardiac blood-pool imaging, Tc-RBC labeled by the in vivo approach appears to be superior to the two Tc-HSA preparations studied.

Citing Articles

Preclinical PET Imaging and Toxicity Study of a Ga-Functionalized Polymeric Cardiac Blood Pool Agent.

Saatchi K, Benard F, Hundal N, Grimes J, Shcherbinin S, Pourghiasian M Pharmaceutics. 2023; 15(3).

PMID: 36986628 PMC: 10052923. DOI: 10.3390/pharmaceutics15030767.


Imaging the Vasculature of Immunodeficient Mice Using Positron Emission Tomography/computed Tomography (PET/CT) and 18F-fluorodeoxyglucose Labeled Human Erythrocytes.

Wang S, Choi J Bio Protoc. 2021; 9(19):e3391.

PMID: 33654883 PMC: 7920323. DOI: 10.21769/BioProtoc.3391.


Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.

Lou C, Chen Z, Bian H, Li J World J Gastroenterol. 2002; 8(1):69-73.

PMID: 11833074 PMC: 4656629. DOI: 10.3748/wjg.v8.i1.69.


Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment:a radioimmunoconjugate for hepatocellular carcinoma imaging.

Bian H, Chen Z, Deng J World J Gastroenterol. 2002; 6(3):348-352.

PMID: 11819595 PMC: 4688749. DOI: 10.3748/wjg.v6.i3.348.


Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function.

Bakker P, Meijburg H, de Vries J, MOWER M, Thomas A, Hull M J Interv Card Electrophysiol. 2000; 4(2):395-404.

PMID: 10936005 DOI: 10.1023/a:1009854417694.